News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,162 Results
Type
Article (13659)
Company Profile (100)
Press Release (249403)
Section
Business (87985)
Career Advice (464)
Deals (15336)
Drug Delivery (64)
Drug Development (36558)
Employer Resources (49)
FDA (6273)
Job Trends (6190)
News (150104)
Policy (14017)
Tag
Academia (435)
Alliances (23181)
Alzheimer's disease (374)
Approvals (6285)
Artificial intelligence (81)
Bankruptcy (144)
Best Places to Work (4360)
Breast cancer (66)
Cancer (468)
Cardiovascular disease (48)
Career advice (406)
Cell therapy (66)
Clinical research (30658)
Collaboration (252)
Compensation (97)
COVID-19 (753)
C-suite (81)
Data (458)
Diabetes (64)
Diagnostics (1277)
Drug discovery (45)
Drug pricing (59)
Earnings (31666)
Events (37057)
Executive appointments (282)
FDA (6552)
Funding (159)
Gene therapy (74)
GLP-1 (315)
Government (1274)
Healthcare (3543)
Infectious disease (775)
Inflammatory bowel disease (50)
Interviews (58)
IPO (5857)
Job creations (2050)
Job search strategy (372)
Layoffs (172)
Legal (3422)
Lung cancer (66)
Manufacturing (118)
Medical device (1267)
Medtech (1269)
Mergers & acquisitions (9596)
Metabolic disorders (200)
Neuroscience (506)
NextGen: Class of 2025 (1582)
Non-profit (592)
Northern California (561)
Obesity (119)
Opinion (113)
Patents (71)
People (28682)
Pharmaceutical (63)
Phase I (7982)
Phase II (12963)
Phase III (11644)
Pipeline (243)
Policy (48)
Postmarket research (1401)
Preclinical (3183)
Radiopharmaceuticals (117)
Rare diseases (125)
Real estate (2632)
Regulatory (9950)
Research institute (563)
Resumes & cover letters (55)
Southern California (550)
Startups (1625)
United States (5531)
Vaccines (127)
Weight loss (86)
Date
Last 7 days (260)
Last 30 days (998)
Last 365 days (12352)
2025 (1019)
2024 (12499)
2023 (14248)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14886)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (46)
Asia (19956)
Australia (2582)
California (1325)
Canada (738)
China (172)
Colorado (52)
Connecticut (54)
Europe (39065)
Florida (228)
Illinois (151)
Indiana (107)
Japan (64)
Kansas (53)
Maryland (197)
Massachusetts (1143)
Minnesota (73)
New Jersey (558)
New York (375)
North Carolina (322)
Northern California (561)
Pennsylvania (345)
South America (500)
Southern California (550)
Texas (171)
Virginia (51)
Washington State (87)
263,162 Results for "saptalis pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Appili Therapeutics Expands ATI-1501 Commercial Agreement with Partner Saptalis Pharmaceuticals
Appili Therapeutics Inc. announced today it has amended its agreement with Saptalis Pharmaceuticals LLC o expand the territories in which Saptalis will commercialize ATI-1501, Appili’s liquid oral reformulation of the antibiotic metronidazole.
February 8, 2022
·
5 min read
FDA
Appili Therapeutics Announces U.S. FDA Approval of LIKMEZ™ (ATI-1501) Metronidazole Oral Suspension
Appili Therapeutics Inc. today announced that its manufacturing and commercialization partner, Saptalis Pharmaceuticals, LLC (“Saptalis”) received approval from the U.S. Food and Drug Administration (“FDA”) for Metronidazole Oral Suspension 500mg/5mL (ATI-1501).
September 25, 2023
·
5 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference
January 30, 2025
·
1 min read
Press Releases
ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference
January 28, 2025
·
1 min read
Press Releases
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
January 27, 2025
·
1 min read
Press Releases
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
January 14, 2025
·
6 min read
Business
Micro Labs USA Inc and Saptalis Pharmaceuticals LLC Announce Launch of Metformin Oral Solution (500 mg/5mL in two presentations 118mL and 473mL)
Micro Labs USA , Inc. and Saptalis Pharmaceuticals, LLC. are strengthening their association with the launch of Metformin Oral Solution in the US market. Metformin Oral Solutio
May 13, 2020
·
3 min read
Press Releases
Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement
January 22, 2025
·
2 min read
Press Releases
Aurora Pharmaceutical Appoints Stephanie Hastings as Director of Marketing
January 28, 2025
·
2 min read
1 of 26,317
Next
